CXCL1 and systemic lupus erythematosus: First, it is suggested that the peak concentration of the secreted chemokine CXCL1 contributes to the stimulation of a large number of autoantibodies in SLE patients in an active disease state, and chemokine dysregulation in SLE have the potential for identifying patient subsets before the onset of clinical disease and during established disease [8].